BILL ANALYSIS Ó
SENATE COMMITTEE ON APPROPRIATIONS
Senator Ricardo Lara, Chair
2015 - 2016 Regular Session
AB 339 (Gordon) - Health care coverage: outpatient prescription
drugs
-----------------------------------------------------------------
| |
| |
| |
-----------------------------------------------------------------
|--------------------------------+--------------------------------|
| | |
|Version: July 16, 2015 |Policy Vote: HEALTH 7 - 2 |
| | |
|--------------------------------+--------------------------------|
| | |
|Urgency: No |Mandate: Yes |
| | |
|--------------------------------+--------------------------------|
| | |
|Hearing Date: August 27, 2015 |Consultant: Brendan McCarthy |
| | |
-----------------------------------------------------------------
*********** ANALYSIS ADDENDUM - SUSPENSE FILE ***********
The following information is revised to reflect amendments
adopted by the committee on August 27, 2015
Bill
Summary: AB 339 would make several changes to existing law
regarding prescription drug coverage and cost sharing for
patients.
Fiscal
Impact:
One-time costs of about $750,000 and ongoing costs of about
$400,000 per year for the Department of Insurance to adopt
policies and regulations, review plan filings, and enforce the
requirements of the bill (Insurance Fund).
One-time costs in the low millions and ongoing costs of about
$500,000 per year for the Department of Managed Health Care to
adopt policies and regulations, review plan filings, and
enforce the requirements of the bill (Managed Care Fund).
AB 339 (Gordon) Page 1 of
?
No significant impact to the Medi-Cal program is anticipated.
The provisions of the bill dealing with cost sharing do not
apply to Medi-Cal managed care plans. The other provisions of
the bill are not expected to significantly increase costs to
Medi-Cal managed care plans.
Author
Amendments: Make changes to the cost-sharing requirements,
delete the requirement that health plans and insurers place
drugs on specified formulary tiers, and make clarifying changes.
Committee
Amendments: Clarify that the cost-sharing requirements for
prescription drugs do not apply to Medi-Cal managed care plans.
-- END --